Patents
Patents for C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
08/2006
08/23/2006CN1821217A Process for producing trans-4-amino-1-cyclohexanecarboxylic acid derivative
08/22/2006US7094777 5-HT2A receptor ligands
08/16/2006EP1087941B1 Thiolesters and uses thereof
08/16/2006CN1820007A Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators
08/15/2006US7091356 Tumor necrosis factor, to inhibit phosphodiesterase in a mammal
08/15/2006US7091229 1,1-Dioxo-2H-naphtho(1,8-cd)isothiazole or 2-oxo-2H-benzo(cd)indole derivatives as anticarcinogenic or antiproliferative agents
08/15/2006CA2215476C Arginine analogues having nitric oxide synthase inhibitor activity
08/10/2006WO2005110406A3 Phenyl derivatives for the treatment of abnormal cell growth
08/08/2006US7087636 A 4,7-methano-1,2-benzisothiazol-3-one-1,1-dioxide derivatives, for treating cancer, immune modulation
08/08/2006CA2200707C Novel prostaglandin synthase inhibitors
08/03/2006US20060173035 3-Aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
08/02/2006EP1684752A1 Phenoxyacetic acids derivatives useful as peroxisome proliferator-activated receptor (ppar) dual agonists
08/01/2006US7084163 Applying to plants
08/01/2006CA2252958C Fungicide salts
07/2006
07/27/2006WO2006077217A1 New 3-phenylpropionic acid derivatives
07/27/2006US20060167268 2-(2-Amino-2-methylpropionylamino)-3-(2,6-difluoro-3-methylphenyl)methoxy propionic acid N-[5-(4-chlorophenyl)-3,3-dimethyl-1,1-dioxo-2,3-dihydroisothiazol-4-ylmethyl]-N-ethylamide; endogenous human growth hormone controller; non-peptidyl in nature, more metabolically stable
07/27/2006US20060167053 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
07/27/2006US20060166999 Use of microsomal triglyceride transfer protein (MTP) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (PPTRL)
07/26/2006EP1682525A2 N-sulfonylaminocarbonyl containing compounds
07/20/2006US20060160870 3-phenylpropionic acid derivatives
07/20/2006US20060160805 Thiotungstate analogues and uses thereof
07/18/2006USRE39198 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesics
07/13/2006WO2006073366A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/13/2006WO2006073365A1 Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators
07/13/2006WO2006073364A1 Derivatives of isothiazol-3 (2h)-thione 1,1-dioxides as liver x receptor modulators
07/13/2006WO2006073363A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/13/2006CA2594404A1 Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/13/2006CA2592771A1 Derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators
07/11/2006CA2217137C Process for preparation of 3-piperazinylbenzisothiazoles
07/06/2006US20060148867 Antagonists to the vanilloid receptor subtype 1 (VR1) and uses thereof
07/05/2006EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase
07/05/2006EP1675587A2 Derivatives of n-(1h-indazolyl)- and n-(1h-indolyl)-urea as well as related compounds as modulators of the vanilloid-1 receptor (vr1) for the treatment of pain
06/2006
06/29/2006WO2006068092A1 Process for production of (4,5-dihydroisoxazol-3-yl)thio- carboxamidine salts
06/29/2006WO2006026034A3 Processes for the preparation of isothiazole derivatives
06/29/2006US20060142587 Benzoisothiazolone compositions
06/28/2006CN1261429C Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles
06/28/2006CN1261404C Method for producing beta ketoenol esters
06/22/2006US20060135783 Multifunctional amine capture agents
06/22/2006US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole
06/21/2006EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity
06/15/2006WO2006062249A1 Substituted heterocyclic compound and thrombopoietin receptor activator
06/15/2006WO2006061135A1 Phenyl-piperazin methanone derivatives
06/15/2006CA2589192A1 Phenyl-piperazin methanone derivatives
06/07/2006CN1784382A 7-amino- isoindolyl compounds amd their pharmaceutical uses
06/01/2006US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses
05/2006
05/31/2006EP1660427A1 Substituted arylalkanoic acid derivative and use thereof
05/26/2006WO2006054102A1 Microcin b17 analogs and methods for their preparation and use
05/26/2006CA2587224A1 Microcin b17 analogs and methods for their preparation and use
05/25/2006US20060111303 N-[(1S)-3-{(2Z)-2-[(4R)-3,4-dimethyl-1,3-thiazolidin-2-ylidene]hydrazino}-2,3-dioxo-1-(tetrahydro-2H-pyran-4-yl)propyl]cycloheptanecarboxamide; cysteine protease inhibitors; for the treatment of inflammatory, immune, ischemic, respiratory,circulatory, neuronal, blood, hepatic and metabolic diseases
05/24/2006EP1658771A1 Benzisothiazoline derivative, plant disease control agent for agricultural or horticultural use, and pest control agent for agricultural or horticultural use
05/24/2006DE102004054847A1 Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament Substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and they drug-containing
05/18/2006WO2006051704A1 Imine compound
05/18/2006WO2006037480A8 Hexafluoroisopropanol substituted ether derivatives
05/18/2006US20060106073 Process for the preparation of epothilone derivatives, new epothilone derivatives as well as new intermediate products for the process and the methods of preparing same
05/18/2006CA2587667A1 Imine compound
05/16/2006US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor
05/10/2006EP1655290A1 Compositions comprising a benzoisothiazolone derivative and their use in the cosmetic field
05/09/2006US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents
05/09/2006US7041670 Florfenicol-type antibiotics
05/04/2006US20060094882 Ambient-temperature molten salts and process for producing the same
05/03/2006EP1652903A1 Isothiazolone containing preservative having enhanced stability
05/03/2006EP1208091B1 Benzophenones as inhibitors of reverse transcriptase
04/2006
04/26/2006EP1648892A2 Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators
04/25/2006US7034052 Anticancer agents; inflammatory bowel disorders; myelodysplastic syndrome
04/20/2006WO2006040351A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents
04/20/2006US20060084809 Compounds as PDE IV and TNF-inhibitors
04/20/2006CA2582180A1 Indazoles, benzisoxazoles and benzisothiazoles, process for preparing them, pharmaceutical compositions and use as estrogenic agents
04/19/2006EP1647549A1 Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
04/13/2006WO2006037480A1 Hexafluoroisopropanol substituted ether derivatives
04/12/2006EP1644322A1 Aspartyl protease inhibitors
04/06/2006US20060074246 4-((Phenoxyalkyl)thio)-phenoxyacetic acids and analogs
04/05/2006EP1641452A1 Heterocyclic compounds useful to treat hcv
04/05/2006EP1519927B1 Method for producing 3,4-dichloro-n-(2-cyano-phenyl)-5-isothiazole carboxamide
04/05/2006CN1754873A Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
03/2006
03/30/2006WO2006016724A3 Liquid-crystalline compounds, compositions and thin films
03/30/2006WO2006008545A3 Thiazole and isothiazole derivatives as protein kinase inhibitors
03/30/2006US20060069037 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
03/21/2006US7015329 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
03/16/2006US20060058362 7-Amido-isoindolyl compounds and methods of their use
03/16/2006US20060058360 Heteroaryloxy/thio propanamines; improved acid stability, potency and selectivity to the dopamine transporter; improved ADME properties e.g. reduced tendency to act as a substrate and/or inhibitor the enzyme Cytochrome P450; pain; [(3R)-3-(Isoquinolin-4-yloxy)-3-phenyl-propyl]-methyl-amine hydrochloride
03/16/2006US20060058315 2-Oxo-ethanesulfonamide derivates
03/15/2006EP1633310A2 Thiotungstate analogues and uses thereof
03/14/2006US7012075 Cathepsin cysteine protease inhibitors
03/14/2006CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors
03/08/2006CN1743320A Saccharin anion ion liquid and its preparing method
03/02/2006WO2004110364A3 Thiotungstate analogues and uses thereof
02/2006
02/23/2006US20060041114 Activators for oligonucleotide synthesis
02/23/2006CA2575188A1 Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer
02/23/2006CA2575056A1 Selected fused heterocyclics and uses thereof
02/22/2006EP1406622B1 Dipeptidyl peptidase inhibitors for the treatment of diabetes
02/21/2006US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors
02/16/2006WO2006015829A1 Compounds which potentiate glutamate receptor and uses thereof in medicine
02/15/2006CN1735592A Hydroxyethylamine derivatives for the treatment of alzheimer's disease
02/08/2006EP1622890A2 Blockers of the quorum sensing system of gram-negative bacteria
02/08/2006EP1404696B1 Activators for oligonucleotide synthesis
02/08/2006EP0812318B1 4-aminotetrahydrobenzisoxazole or -isothiazole compounds
02/02/2006US20060025459 Having Asp2 ( beta -secretase, BACE1 or Memapsin) inhibitory activity, for therapy of diseases characterised by elevated beta -amyloid levels or beta -amyloid deposits
02/02/2006US20060025453 inhibitor for treating a chemokine mediated disease; cancer, angiogenesis, angiogenic ocular diseases, pulmonary diseases, multiple sclerosis, rheumatoid arthritis, osteoarthritis, stroke and cardiac reperfusion injury, pain
02/01/2006EP1620412A2 Heterocyclic compounds and hydro isomers thereof
02/01/2006CN1729197A Tetracyclic 3-substituted indoles having serotonin receptor affinity
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 50